Suboxone tablets

In October 2002, the FDA approved two new medications for treating opiate addiction, both developed by Reckitt Benckiser Pharmaceuticals. The new drugs, Subutex (buprenorphine hydrochloride) and Suboxone tablets (buprenorphine hydrochloride and naloxone hydrochloride) contain buprenorphine, a partial opioid agonist. Like methadone, buprenorphine binds to the brain s opioid receptors, but produces significantly reduced pleasurable effects than heroin. 

Suboxone tablets (buprenorphine hydrochloride and naloxone hydrochloride)... 

Voltarol is a brand-name preparation for diclofenac (NSAID) and modified-release tablets are available in 75 mg and 100 mg strength. Nu-seals is a proprietary preparation of enteric-coated aspirin 75 mg. Fentanyl, co-codamol and Suboxone (buprenorphine and naloxone) consist of opioid drugs. 

Suboxone is a combination of buprenorphine (opioid partial agonist) and naloxone. It is presented as sublingual tablets and is used as an adjunct in the treatment of opioid dependence and in premedication or perioperative analgesia. A side-effect of opioids is drowsiness. 

Tablets, sublingual 2 mg buprenorphine base/0.5 mg naloxone, 8 mg buprenorphine base/2 mg naloxone (C-/77) Suboxone (Reckitt Benckiser)...

Use ofbuprenorphine Buprenorphine is a sublingual tablet available as either Subutex, which is monotherapy, or Suboxone, which is a combination of 4 mg ofbuprenorphine and 1 mg of naloxone. 

Buprenorphine and naloxone Sublingual Tablet Suboxone Reckitt Benckiser... 

---